Arrowhead to Present at Upcoming Conferences
PASADENA, Calif.–(BUSINESS WIRE)–
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical
company developing targeted RNAi therapeutics, today announced that the
Company will present at upcoming investor and scientific conferences.
Investor Conferences
-
Jefferies 2014 Global Healthcare Conference on Thursday, Nov. 20 at
12:20 p.m. GMT in London
-
7th Annual 2014 Deutsche Bank BioFEST on Monday, Dec. 1, at
11:35 a.m. EST in Boston
-
26th Annual Piper Jaffray Healthcare Conference on
Wednesday, Dec. 3, at 3 p.m. EST in New York
Investors may access a live and archived audio webcast of these
presentations on the Company’s website at http://ir.arrowheadresearch.com/events.cfm.
Scientific Conferences
-
15th Annual EuroTIDES meeting on Wednesday, Nov. 19, at 5
p.m. CET in Berlin
About Arrowhead Research Corporation
Arrowhead Research Corporation is a biopharmaceutical company developing
targeted RNAi therapeutics. The company is leveraging its proprietary
Dynamic Polyconjugate delivery platform to develop targeted drugs based
on the RNA interference mechanism that efficiently silences
disease-causing genes. Arrowhead’s pipeline includes ARC-520 for chronic
hepatitis B virus, ARC-AAT for liver disease associated with Alpha-1
antitrypsin deficiency, and partner-based programs in obesity and
oncology.
For more information please visit http://www.arrowheadresearch.com,
or follow us on Twitter @ArrowRes.
To be added to the Company’s email list and receive news directly,
please visit
http://ir.arrowheadresearch.com/alerts.cfm.
Source: Arrowhead Research Corporation
Company:
Arrowhead Research Corporation
Vince Anzalone,
CFA
626-304-3400
ir@arrowres.com
or
Investor
Relations:
The Trout Group
Lauren Glaser
646-378-2972
ir@arrowres.com
or
Media:
Russo
Partners
Martina Schwarzkopf, Ph.D.
212-845-4292
martina.schwarzkopf@russopartnersllc.com
Source: Arrowhead Research Corporation
News Provided by Acquire Media